{
  "patent_number": "US 10307490",
  "country": "US",
  "title": "Tiny Packages for Delivering Gene-Targeting Drugs to Specific Cells",
  "original_title": "Lipid nanoparticle compositions for antisense oligonucleotides delivery",
  "summary": "This patent describes a method to create tiny, targeted packages made of lipids and proteins that can deliver specific gene-modifying drugs, like antisense oligonucleotides, directly to certain cells in the body.",
  "what_it_does": "This patent describes a special type of tiny package called a lipid-coated albumin nanoparticle (LCAN) designed to deliver therapeutic agents. The LCAN is built around a core that is positively charged and contains an albumin-polycation conjugate, as specified in claim 1. This core can encapsulate a therapeutic agent, such as an antisense oligonucleotide (ASO) that targets genes like Akt-1 or HIF-1, as detailed in claims 2 and 3. The entire core is then wrapped in a positively-charged lipid layer, called a cationic liposome. Crucially, the nanoparticle also includes a 'targeting agent' (claim 1), which acts like a homing beacon to guide the package to specific cells or tissues, using molecules like RGD peptides or folate (claim 8). For example, this system could deliver an ASO to cancer cells, blocking a gene that helps them grow, while minimizing effects on healthy cells.",
  "what_it_does_not_cover": [
    "Does not cover drug delivery systems that do not use a lipid-coated albumin nanoparticle (LCAN) structure as defined in claim 1.",
    "Does not cover nanoparticles where the core is not net positively-charged or does not contain an albumin-polycation conjugate.",
    "Does not cover delivery systems that lack a specific targeting agent to direct the nanoparticle to certain cells.",
    "Does not cover lipid nanoparticles that are purely anionic or neutral in charge, as the claims specify a 'cationic liposome' and a 'net positively-charged core'.",
    "Does not cover delivery of therapeutic agents that are not encapsulated within the core of the nanoparticle."
  ],
  "filed": "2013-05-23",
  "granted": "2019-06-04",
  "expires": "2033-05-23",
  "status": "active",
  "holder": "The Ohio State University",
  "holder_url": "https://patentbrief.org/company/the-ohio-state-university",
  "inventors": [
    {
      "name": "Young Bok Lee",
      "url": "https://patentbrief.org/inventor/young-bok-lee"
    },
    {
      "name": "Chang Ho Ahn",
      "url": "https://patentbrief.org/inventor/chang-ho-ahn"
    },
    {
      "name": "Deog Joong Kim",
      "url": "https://patentbrief.org/inventor/deog-joong-kim"
    },
    {
      "name": "Robert J. Lee",
      "url": "https://patentbrief.org/inventor/robert-j-lee"
    }
  ],
  "times_cited": 3,
  "tags": [
    "biotech",
    "pharmaceutical",
    "nanotechnology",
    "gene_editing"
  ],
  "abstract": "Described is a lipid nanoparticle composition that includes a macromolecule conjugated to a polymer and a targeting agent. The composition can include a therapeutic agent. The therapeutic agent can be an antisense oligonucleotide (ASO). Exemplary ASOs are targeted to a portion of a nucleic acid encoding Akt-1, and which modulates the expression of Akt-1; or targeted to a portion of a nucleic acid encoding HIF-1, and which modulates the expression of HIF-1. Also described is a lipid nanoparticle composition that includes a macromolecule conjugated to a polymer and a therapeutic agent that is an ASO such as an ASO targeted to a portion of a nucleic acid encoding Akt-1, and which modulates the expression of Akt-1 or an ASO targeted to a portion of a nucleic acid encoding HIF-1, and which modulates the expression of HIF-1. Pharmaceutical formulations, methods of making the lipid nanoparticles, and methods of using the lipid nanoparticles, for example for treating cancers, are also disclosed.",
  "url": "https://patentbrief.org/patent/us/10307490/lipid-nanoparticle-compositions-for-antisense-oligonucleotides-delivery",
  "markdown_url": "https://patentbrief.org/patent/us/10307490/lipid-nanoparticle-compositions-for-antisense-oligonucleotides-delivery/md",
  "google_patents_url": "https://patents.google.com/patent/US10307490",
  "relatedPatents": [
    {
      "patentNumber": "11464870",
      "countryCode": "US",
      "title": "Tiny Fat Bubbles That Deliver Drugs Directly to the Liver",
      "url": "https://patentbrief.org/patent/us/11464870/lipid-nanoparticles-for-in-vivo-drug-delivery-and-uses-thereof"
    },
    {
      "patentNumber": "20250235403",
      "countryCode": "US",
      "title": "Tiny Bubbles for Delivering Medicine",
      "url": "https://patentbrief.org/patent/us/20250235403/compositions-and-methods-of-the-delivery-of-active-agents-including-nucleic-acid"
    },
    {
      "patentNumber": "10155945",
      "countryCode": "US",
      "title": "How to Build Tiny Lipid Capsules to Deliver Genetic Medicines",
      "url": "https://patentbrief.org/patent/us/10155945/method-of-producing-lipid-nanoparticles-for-drug-delivery"
    },
    {
      "patentNumber": "20190046446",
      "countryCode": "US",
      "title": "How Special Nanoparticles Deliver Cancer Drugs Directly to Tumors",
      "url": "https://patentbrief.org/patent/us/20190046446/apo-e-modified-lipid-nanoparticles-for-drug-delivery-to-targeted-tissues-and-the"
    },
    {
      "patentNumber": "20190307892",
      "countryCode": "US",
      "title": "Targeting Drugs to Specific Body Tissues Using ApoE3-Coated Nanoparticles",
      "url": "https://patentbrief.org/patent/us/20190307892/targeted-drug-delivery-and-therapeutic-methods-using-apo-e-modified-lipid-nanopa"
    }
  ]
}